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ANTIMONY PREPARATIONS IN THE TREATMENT OF MYCOSIS
FUNGOIDES *
JOHN GARB, M.D.
On October 24, 1948, eighteen months after beginning the studies described
below and a short while after the publication of my first report (1) I found two
references to the earlier experimental use of tartar emetic in mycosis fungoides.
Two cases of mycosis fungoides were presented from the Barnard Free Skin and
Cancer Hospital by Dr. G. D. Reeves (2) at the St. Louis Dermatological Soci-
ety on January 8, 1930 showing "decided improvement with antimony and
potassium tartrate." Two patients were presented by Dr. H. D. Shaw (3) before
the Dermatological Conference of the Mississippi Valley on December 6, 1930.
One of them was treated with tartar emetic injections 3 times weekly for four
months. There was no improvement although the progress of the disease was
retarded. The patient was then treated with filtered doses of roentgen rays with
"marked improvement." The second patient, a woman aged 53, was treated
likewise with "only slightly more improvement."
No further records of the treatment of mycosis fungoides with antimony have
thus far been found. Apparently the results were discouraging and this method
of treatment was discontinued.
The present contribution will be limited to a report on recent results of treat-
ment of mycosis fungoides with antimonials and to a discussion of the mode of
administration. Particular reference will be made to the dosage and to suggestions
for the experimental use of various antimony compounds alone or in combina-
tions with other forms of therapy.
Ten cases of mycosis fungoides have been under my care at the Skin and
Cancer Unit of the New York Post-Graduate Medical School and Hospital since
April 28, 1947. In two cases, the disease was of about six months' duration and
in seven, from four to seventeen years' duration. The lesions varied from the
infiltrative to the tumor and ulcerative stages.
The antimony preparations used were tartar emetic, 5 cc. of a 1 per cent solu-
tion in distilled water givefl intravenously, Fuadin 5 cc. and Stibanose 4 to 8 cc.
given intramuscularly.'
*From the New York Skin and Cancer Unit, Department of Dermatology and Syphilol-
ogy (Dr. Marion B. Sulzberger, Director), Post-Graduate Medical School, New York
University-Bellevue Medical Center.
Received for publication June 22, 1949.
'Tartar emetic (antimony and potassium tartrate, K(SbO)C4H405IH,O) is trivalent,
marketed in S cc. ampules of 1% solution. Each ampule contains 50 mg. of the drug, 36.47%
metallic antimony.
Fuadin (antimony III bis-catechol 2,4-disulfonate of sodium) is trivalent, marketed
in ampules of 3.5 and 5 cc., 1 cc. containing 8.5 mg. of antimony.
Stibanose is pentavalent, marketed in ampules of 4 cc., 1 cc. containing 20mg. of anti-
mony. The chemical formula was already given in a previous publication. See reference 1,
p. 46.
Fuadin and Stibanose were kindly supplied by the Department of Medical Research,
Winthrop-Stearns, Inc., New York.
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Routine and special laboratory tests including chemistry of the blood, electro-
cardiograms, liVer function tests (icteric index, Hangers' and thymol turbidity
tests) and sedimentation rates were done before the treatments and repeated
about once a month.
REPORT OF CASES
Case 1: ID. N. (1), a woman aged 49, the first patient treated, had generalized lesions of
over eight years' duration. She had extensive infiltrated patches, tumorous growths and
Fin. 1. Case 1. May 23, 1947, Showing lesions on the lower limbs after 10 intravenous in-
jections of tartar emetic had been given between April 28 and May 19, when there was
improvement of about 50 per cent. Note: Figs. 1, 3 & 5 are reproduced from the article
on Mycosis Fungoides in the J. Invest. Dermat. 10: 43 (Feb.) 1948 to compare with the
respective Figs. 2, 4 & 6.
numerous ulcerations. Her general condition was gradually but steadily deteriorating.
She received from April 24, 1947 until October 30, 1948 successively a total dosage of 10
injections of tartar emetic, the individual doses being administered three times weekly,
73 injections of Stihanose 4 cc. and 42 injections of Fuadin at twice weekly intervals. The
total antimony used was 7.80 Gm. Antimony medication has been continued in the hope of
clearing up the 4 residual, moderately infiltrated, cherry to walnut-sized patches on the
right leg and left buttock (figs. 1 to 6).
The patient feels well. She had a rest from treatments from August 11 to October 6,
1947 and later another interval of ten days. The first prolonged rest was given because of
minor electrocardiographic changes which subsequently reverted to normal and remained
FIG. 2. Case 1. November 22, 1948, Showing lesions on the lower limbs disclosing only 2
residual patches on the lower third of the inner surface of the right leg.
Fin. 3. Case 1. August 8, 1947, Showing the lesions on the front of the body.
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Pie. 4. Case 1. November 2, 1948, Showing the lesions on the front of the body.
Pie. 5. Case 1. August 8,1947, Showing the lesions on the back of the body.
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so since. She has been in apparent excellent health and good spirits with no subjective
complaints since the improvement with antimony began. Not a single new lesion appeared
during the treatment with antimonials. Local therapy was never used.
It is interesting to note that a histologic section taken from the infiltrative lesion of
tbe left leg (fig. 2) on November 2nd, 1948 still showed the characteristic histologic struc-
ture of mycosis fungoides. A hemogram taken on the same date was normal except for a
relative lymphocytosis of 47 per cent.
The pigmented patches of some of the healed lesions, most pronounced on the lower
extremities and varying from dark brown to brownish black, have gradually become much
ighter.
Fin. 6. Case 1. November 2, 1948, Showing lesions on the back of the body.
Case 2: C. F., a woman aged 52, on December 8, 1947 presented skin lesions of six months'
duration. There were diffuse nodular growths on the scalp, infiltrated patches on the right
upper eyelid, shoulders, back and front of cbest, axillae, upper and lower limbs and finger
nails. In the middle of the inner surface of the right thigh was a growth 2 cm. by 4 cm. in
size. The patient complained of very severe itching. Roentgen therapy was never used.
From December 5, 1947 until May 9, 1948 the patient received 26 injections of tartar
emetic and 19 Stibanose injections of 8 cc. each, a total of 3.35 Cm. of antimony. There
was pronounced diminution of itching after the first and noticeable regression of lesions
after the third injection of tartar emetic. Throughout the entire course of tartar emetic
injections, except during the first 3, the patient complained of pains in the shoulders dur-
ing injections and of weakness, dizziness and tired feeling about six hours later, which
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lasted for twenty-four hours. She developed on 3 occasions a localized phlebitis of the
cubital veins which later resolved. The electrocardiogram remained normal. All labora-
tory data including repeated electrocardiograms have been normal except the hemogram
which showed a hypochromic anemia.
Magnesium and zinc oxide lotion for lesions in the axillae and boric acid salve for the
right upper eyelid were the only local treatments used. Lextron2 was given for the anemia.
No new patches appeared since treatment with antimony was instituted. The patient has
been entirely free of lesions from May 9 until her last examination on November 26, 1948.
The tumorous growth on the right thigh completely regressed, leaving a thinned dark-
brown pigmented scar. The infiltrated patch on the right upper eyelid was the last to un-
dergo resolution.
Even the blackish-pigmented horizontal patches at the junction of the nail plates with
the free borders of the nails have almost completely undergone involution. This is the
first time the author has observed such pigmentation in the nails in mycosis fungoides.
FIG. 7. Case 2. November 24, 1947, Showing the patches on front of the upper part of the
chest, right supra- and infraclavicular regions.
It is of interest to note the spreading in area of the patches corresponding with the
symptomatic improvement and the flattening, paling and thinning of the lesions (compare
Fig. 7 with Fig. 8).
Case 3: V. F., a man aged 47, had lesions of fifteen years' duration. They were located
on the neck, chest, groins and thighs and consisted of infiltrated patches and nodular
growths. From October 28, 1946 to May 23, 1947 the patient received 14 unfiltered, roent-
gen ray exposures to all lesions, one-quarter skin unit each, a total of 1050 r.
Sixteen injections of tartar emetic were given from December 15, 1947 until January 28,
1948, a total of .26 Gm. of antimony. On December 19, after only 2 injections of 3.5 cc. each
the lesions had already shown signs of regression. The patient complained once of dizzi-
ness immediately following an injection given after a heavy meal.
Treatment was discontinued on January 28 because of toxic condition of the myocar-
dium which could not he definitely attributed to antimony. On February 20 the electro-
cardiogram was reversed to normal. The lesions had regressed except for residual superficial
Lextron, a proprietary liver-stomach concentrate with iron and vitamin B complex.
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scaly patches on the abdomen and thighs. No new lesions appeared during treatment
with antimony. Local therapy was not used. There was no itching since involution of the
lesions. Examination oa October 20 revealed a few new raised somewhat infiltrated patches
on the left side of the ncck and in the pelvic and lumbar regions at thc areas of irritation
from the collar and pressure from a leather belt. One per cent Vioform (Ciba) was pre-
scribed for these lesions. On November 26 only superficial slightly scaly pea to bean-sized
patches were seen at the aforemcntioned areas.
In spite of the normal elcctrocardiographic report there were still clearly audible sys-
tolic murmurs at thc three valve areas of the heart. It was therefore considered a risk to
treat this patient even with weekly injections of 4 cc. of Stibanose, the least toxic of the
antimony preparations.
In this ease as in ease 2, hut to a lesser degree, there was considerable spreading out of
the patches concomitant with flattening and regression of the lesions.
Fin. S. Case 2. December 31, 1947, Showing the lesions of Fig. 7 which have almost com-
pletely undergone involution. This photograph also shows the considerable spreading of
the patches. The same spreading of the patches occurred also in the lesion on the left shoul-
der and in the tumorous growth of the inner surface of the right thigh.
Case 4: D. K., a man aged 75, had lesions of seven years' duration. On February 9,
1948 the patient presented generalized and profuse infiltrated patches and tumorous
growths. Twenty injections of tartar emetic were administered from February 17 until
April 2, 1948, a total of 0.36 Gm. of antimony. They were given 3 times weekly before break-
fast, the patient resting for one hour after injection. There was a partial regression of
some of the tumors and of the superficial flat patches. There were no subjective complaints
and no local reactions during or after the injections. Local therapy was not used.
From April 19 until September 18, 1948 the patient received 7 injections of 4 to S cc. of
Stibanose and 29 injections of Fuadin. The total amount of antimony given was 2.47 Gm.
The lesions were slowly undergoing regression. The patient continued to complain of
some itching, especially on the back. No treatment was administered from September 15
until October 15 and condition has been stationary. The treatment is now being continued
with injections of Fuadin once to twice weekly. Since November 22 the patient has been
treated concomitantly with mild ultraviolet ray exposures. During the past two weeks the
lesions have undergone partial involution.
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Case 5: R. N., a woman aged 40, had lesions of about four years' duration. The first
series of 10 x-ray treatments given in 1945 together with arsenicals relieved the severe itch-
ing and caused regression of the patches for four months. New lesions appeared during
the second series of 10 x-ray treatments. The last exposure was given in February 1947.
The patient presented generalized lesions consisting of large infiltrated patches and
some nodular growths. She was treated from December 3, 1947 until February 6, 1948 with
6 injections of tartar emetic and 18 of Stibanose, 16 of the latter of 4 cc. each and 2 of 8 cc.
each. The tartar emetic injections had to be discontinued because the cubital veins were
unusually small and local phlebitis developed. Thirteen Fuadin injections were given from
March 3 until April 2, 1948. A total of 2.26 Cm. of antimony was administered.
There was no response and no abatement in the itching. New patches appeared during
the treatment. The lesions spread out considerably. The patient was referred for roent-
gen ray treatment to which she responded well. Many new lesions however have been ap-
pearing during and since the roentgen ray treatment.
Case 6: II. F., a woman aged 61, had skin lesions of t\venty-t\vo months' duration. The
itching was intense, intolerable and uncontrollable. There was a concomitant coronary
sclerosis. Nineteen Stibanose injections were given, at first 4 cc. later 8 cc. each, three
times weekly. A total of 2.3 Cm. of antimony svas administered. The patient received lit-
tle relief from itching with slight regression of some of the nodular and infiltrated lesions.
She died a few months later from cardiovascular and renal complications.
Case 7: F. i{., a man aged 42, had generalized, infiltrated and tumorous growths of
about six months' duration. He was hospitalizcd at the Post-Graduate Hospital on June
15, 1948 for four months, being bedridden the latter two months. He received at first 20
injections of tartar emetic and later Fuadin nnd Stihanose injections. Various forms of
supportive therapy including injections of extract of liver, testosterone propionate, pro-
longed courses of penicillin injections and protein hydrolysate feedings were given. The
patient showed encouraging signs at first but later developed pneumonia and deteriorated
rapidly. Death followed ncutc myocarditis with pleural effusion. The gross pathologic
findings of the autopsy were as follows:
Mycosis fungoides
Lymphadenopathy, inguinal and axillary lymph nodes
Fibrosis, post-rheumatic, mitral valve
Acute bacterial endocarditis, mitral valve
Dilatation of right ventricle
Congestion of lungs, liver and kidneys
Infarcts of spleen
Atelectasis of lungs
Bilateral hydrothorax
Ascites
Adenoma of left kidney
Adenoma of right adrenal gland
Edema of scrotum
Decubitus ulcers of sacrum
Healed fractures of the right sixth, seventh and eighth ribs
Examination of the viscera and the histologic sections of the lymph nodes by Dr. Mau-
rice N. Richter did not reveal any changes related to mycosis fungoides.
Cast 8: C. C., a man aged 44, had generalized lesions of seventeen years' duration.
They consisted of superficial, crusted infiltrated patches and nodular growths. Tartar
emetic was not given because of heart block.
This patient was treated from December 10, 1947 until February 13, 1948 with injec-
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tions of Stibanose 4 cc. each later increased to 8 cc. each three times weekly, a total of 92
cc. From March 8 until April 7 he received 13 Fuadin injectioos. The total amouot of anti-
mouy used was 2.39 Gm.
There was perhaps some regression of the lesions and a lesseniog of infiltration espe-
cially oa the neck. The lesions on the trunk and extremities did not change appreciably.
The patient complains of only occasional itching. The treatment with antimony is being
carried out irregularly depending upon the condition of the myocardium.
Case 9: 8. S., a man aged 63, had skin lesions of seventeen years' duration. He had
many very large tumors and extensive deep ulcerations on the trunk and extremities, some
being very painful. He was treated from December 15, 1947 until February 3, 1948 with 16
Stibannse injections, 9 of 4 cc. and 7 of 8 cc. each, a total of 0.18 Gm. of antimony. There
were signs of healing of some of the ulcerations, especially those of the right wrist and the
posterior surface of the left leg. He complained constantly of pain in some of the ulcer-
ations. After 2 tartar emetic injections of 2.5 cc. and 5 cc. the wounds became more pain-
ful. Ten Fuadin injectionswere given from April 2 until April 12, 1948 with no appreciable
benefit. The patient refused to take further antimony injections.
Case 10: J. B., a man aged 64, had skin lesions of eight months' duration. They were
located on the lower half of the abdomen, inner surfaces of the thighs and genitals. The
lesions were diffuse, infiltrated and edematous.
From January 26 until April 12, 1948 he received 13 Stibanose injections, 4 cc. each, 2
tartar emetic, 3 cc. each and 5 Fuadin injections, 3.5 cc. each. The total antimony used
was 1.74 Gm.
Pustular lesions covered with yellowish crusting developed on the scalp, oozing patches
on the scrotum and a pinpoint to pinhead-sized generalized papulo-vesicular rash on the
trunk nnd extremities. The eruption was most pronounced after tartar emetic injections
when he was obliged to stay in bed for a week after each injection, aggravating the general
asthenia and sweating of which he complained before treatment was begun. The drug
eruption and reaction was also pronounced after Fuadin but less so after Stihanose.
PLAN OF TREATMENT
The following is the general plan of treatment which has been adopted for
the present: Using a dry 22-guage needle, tartar emetic 1 per cent solution is
given intravenously 3 times weekly for 20 inj eetions. The first t\vo injections are of
2.5 cc. and 3.5 cc. respectively and the following doses are of 5 cc. each. The injec-
tions are given while the stomach is empty or one to two hours after a light meal.
The patient rests for ten minutes to one hour after the injection. The one per
cent tartar emetic solution in ampule was in the later courses mixed with an equal
amount of distilled water, making a solution of about per cent concentration.
This seemed to lessen the incidences of complications, especially the pains in the
shoulders and phlebitis of the cubital veins. If tartar emetic is contraindicated,
Fuadin 5 cc. or Stibanose S cc. each are given intramuscularly three times
weekly.
The urine is examined once weekly. A hemogram, liver function tests (icteric
index, Hangers' and thymol turbidity) and an electrocardiogram are taken once
a month. The injections should be discontinued for one to two weeks about every
six to eight weeks, depending upon the general condition and the results of the
laboratory data.
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COMMENT
Cases 1 and 2 are to date clinically and symptomatically practically well and
with no recurrences since the treatment with antimony began. Case 3 presented
new lesions at the points of friction from the collar of the shirt and at areas of
pressure and contact with a leather belt. After friction from wearing apparel was
eliminated and following application of 1 per cent Vioform salve, only superficial
scaly patches were seen when the patient was re-examined one month later.
There was no evidence of development of other lesions.
It is of course impossible to predict the future courses of these cases. They
will be watched and examined periodically for possible recurrences. In cases 1, 2
and 3 the antimony appeared to act almost as a specific, case 1 showing a pro-
nounced transformation for the better in three weeks, after 10 intravenous in-
ections of tartar emetic and case 2 experiencing a decided diminution of itching
after the first and revealing a noticeable regression of the lesions after the third
injection of tartar emetic. Some of the lesions were flattening out, became less
scaly and were changing in color from "flaming red to chocolate brown." Perhaps
the explanation for the occurrence of new lesions in this case (unless they were
solely patches of contact dermatitis from the collar and the leather belt) may be
that the patient received insufficient treatment, a total of only 16 tartar emetic
injections. Although no conclusions can be drawn from observation and study
of one patient, it may nevertheless be justifiably advocated, as a preventive
measure, to continue antimony treatments experimentally for six months after
all or almost all the lesions have regressed, preferably with 5 cc. of Fuadin or 8 cc.
of Stibanose.
From this small series of only 10 patients the following facts seem to stand
out fairly clearly: The first 3 cases which responded well and rapidly received
initial courses of 10, 16 and 26 antimony and potassium tartrate injections
respectively. Case 4 however responded only moderately well after 20 injections
of tartar emetic. Case 5 which showed no response to the antimonials received
only 5 tartar emetic injections of a total of 22.5 cc. of 1 per cent solution be-
cause of small cubital veins with resulting phlebitis; case 6 which responded
only partially was treated only with Stibanose because of coronary heart dis-
ease; case 8 which responded slightly and partially was treated at first with
Stibanose and later with Fuadin because of heart block and case 9 which showed
encouraging signs at first and disappointing results later received only 2 injections
of tartar emetic. However, even case 1 which has improved so spectacularly but
which still has 4 residual patches received initially only 10 tartar emetic in-
jections.
These data seem to suggest that of the 3 preparations tartar emetic is the drug
of choice and should be given initially in adequate courses of 20 or more in-
jections.
It is worthy of comment that cases 2 and 3 which responded so promptly to
the antimony treatments showed very early considerable spreading of the patches
concomitant with the diminution in itching and thinning out of infiltration.
This phenomenon may even be considered as a possible index of response to
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the treatment with tartar emetic with an indication of early complete regression
of the lesions.
This reaction may be the expression of the response of the reticulo-endothelial
system in which the skin plays a major role. This defense system is represented
by the Langerhans cells in the cutaneous structures and by the endothelium of
the papillary blood and lymph capillaries. It thus "serves to explain the fact
that both the epidermis and the cutis are, in principle, capable of producing
antibodies (4)." Sulzberger (5) also states that "future studies may prove that
the cutaneous tissues regularly play an essential part in the production of changes
in capacity to react, and perhaps even in the elaboration of antibodies." Kauff-
man (6) likewise expressed an opinion that conclusions could be drawn as to the
functional state of the reticulo-endothelial system in general by the examination
of local skin reactions.
It is certainly disappointing that more patients in this series did not improve.
Nevertheless the rapid improvement in cases 1, and 3 suggests that antimony be
further and fully explored for its possibilities in mycosis fungoides and related dis-
eases of the reticulo-endothelial system. I believe that every case of mycosis fungo-
ides, unless the medication be contraindicated by myocardial, liver or kidney
affection, should receive an initial trial treatment with tartar emetic. Judging by
the results in 3 cases, if a favorable response is to be expected it will usually be
manifested within three to six weeks by considerable diminution of itching and
by pronounced regression of lesions. Patients who show a good or moderately
good initial response and who later fail to show continued progress but no evi-
dence of progression of the disease should receive the antimony treatments in
moderate doses for long periods of time, perhaps simultaneously with fractional
doses of roentgen rays. Of course all patients must be checked periodically for
possible myocardial, liver and kidney intoxication. The rationale of treating
with x-rays is to increase the effects on the reticulo-endothelial system which the
antimony alone in the dosage given with safety is apparently unable to accom-
plish. It may be that x-ray exposures of any section of the skin involved may
be sufficient to hasten resolution of other lesions. Schreiner and Wendlberger (7)
believe that x-rays stimulate the reticulo-endothelial system regardless of the
region they enter the body.
It is possible that even in cases in which the skin does not show a favorable
response, the antimony treatment may not be entirely in vain. It may be per-
missible to assume that Shaw's patient (2) showed "marked improvement" after
treatment with filtered doses of roentgen rays because of the previous tartar
emetic administration. Similarly case 5 which did not respond to antimony and
appeared to be even worse, responded subsequently more rapidly to x-ray ther-
apy than to the course given before the antimony treatments were administered.
Massive doses of antimony may perhaps be attempted in selected cases of my-
cosis fungoides, as in the treatment of schistosomiasis studied by Ritckken and
Kantor (8). These investigators gave 1 grain (65 mgs.) of antimony and potas-
sium tartrate per 12 pounds (5.45 kg.) of body weight, this total being given in
divided doses of 6 intravenous injections during twenty-four hours. The individ-
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ual doses are mixed in 10 cc. of 5 per cent glucose in normal saline and given
slowly over a period of 5 to 10 minutes.
A change in the antimony preparation during the course of treatment might
possibly be of benefit, as in case 1, where Stibanose failed to clear up the residual
lesions which, however, began to undergo further involution after injections of
Fuadin. The subsequent lack of response to Stibanose after the continued and
steady improvement earlier may have been the result of "drug fastness" or due
to the switch to the more potent antimonial, the trivalent Fuadin.
Antimony compounds other than those used in this series of cases may be
worth investigating. This is exemplified by the case of Dr. Max Berkovsky (9)
at the Bronx Dermatological Society. This patient, a man aged 56 years, had
mycosis fungoides of eight months' duration when seen in August 1947. The le-
sions were widespread and consisted of variously-sized superficial, dry, moist
and oozing patches of dermatitis purplish in color and irregularly distributed.
They were resistant to various types of local therapy. Neostibosan* 0.3 Gm.
was then administered intravenously once weekly with "significant betterment"
after the third injection. Almost all of the lesions underwent involution after 10
injections. There was no more itching. Two months after the last injection a
few new lesions appeared associated with some mild itching. A second course of
Neostibosan was then given. The effect was "dramatic." The new lesions disap-
peared after 1 injection and the itching ceased.
Apparently in various diseases in which antimony seems to have beneficial
action, e.g., in leishmaniasis, trypanosomiasis, bilharziasis and granuloma ingui-
nale, the result depends more upon the type of the antimony compound than
upon the metal itself. Each of these diseases seems to have its own particular
type of antimony compound or compounds to which it responds best. Chen and
his associates (10) in investigating the trypanosomicidal activity of antimonials
in mice infected with trypanosome equiperdum found that in order of descending
effectiveness were Stibamine, derivative of phenyl stibinic acid, Fuadin and
tarter emetic. Urea-stibamine, the carbamide salt of para-amino-phenyl-stibinic
acid, Neostibosan and Stibanose are preferred iii kala azar; Fuadin (Stibophen),
Anthiomaline (antimony and lithium thiomalate) in large doses are the drugs of
choice in bilharziasis (11).
The impression has been gained from this small series and from isolated re-
ports of other observers that the more extensive and severe cases of mycosis
fungoides, for example those in the tumor and ulcerative stage and of long du-
ration, responded more rapidly to antimony medication. However, case 2 which
had infiltrative, nodular lesions and a tumor of only six months' duration re-
sponded rather spectacularly.
Studies are now being undertaken of the infiltrate with reference to the num-
ber of the reticulo-endothelial cells similar to those made by Henstell and his
* Neostibosan is a powder put up in ampules, 0.3. Gm. each, which is dissolved in 6 cc.
of distilled water. It is a pentavalent antimony compound, brand of Ethyistibamine (An-
timony complex of p-aminophenylstibonic acid, p-acetylaniinophenylstibonic acid, anti-
monic acid and diethylamine), marketed by Winthrop-Stearns, Inc., New York.
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associates (12) in cases of mycosis fungoides treated with nitrogen mustard.
Henstell et al. (13) found a direct correlation between the clinical improvement
and the number of the reticulo-endothelial cells. Thus 3 cases which showed the
best response had a high incidence of reticulo-endothelial cells while 3 other
cases which responded the least had a low percentage of these cells. A clear rela-
tionship in dermatologic diseases between the state of the reactivity of the body
and the percentage of histiocytes was also observed by Schreiner and Wendi-
berger (14). An unfavorable course of the disease was accompanied by a low
percentage of histiocytes and vice versa.
Stratton (15) injected emulsified tissue from lesions of mycosis fungoides into
the brains and peritoneal cavities of mice. One of the brain-injected mice devel-
oped an enlarged liver 5 times and spleen 20 times its size. A mouse injected
intraperitoneally developed an enlarged spleen, 10 times its size. Histologic sec-
tions of these organs showed infiltrations similar to the structure of mycosis
fungoides. Stratton (16) believes that if there could be a correlation between
mycosis fungoides in man and the reaction observed in the mouse it would
"favor the theory of a toxin or a virus as the etiological agent in mycosis fungo-
ides."
Virus studies were performed only in case 9. Inoculations of the discharge
from the ulcerated lesions into embryonated eggs and cornea of a rabbit gave
negative results. These studies will be continued in other cases.
SUMMARY
It is deemed justifiable to recapitulate some of the outstanding findings in the
10. cases of mycosis fungoides treated with antimonials.
The good results in the first 3 cases may have been due to adequate initial
courses of tartar emetic despite the partial or complete failure of the antimonial
preparations in the remaining 7 cases.
There seems at present to be no known reason why antimony should seem to
effect favorable responses in 3 out of 10 patients and in the others act only poorly
or not at all. One explanation might be that mycosis fungoides is not a disease
entity when regarded with respect to etiology.
This report has been restricted mainly to practical aspects of treatment of
mycosis fungoides with antimonials and suggestions for modifications in the
treatment in those cases in which response is not satisfactory.
Despite its effectiveness in only 3 out of 10 cases the recommendation is made
that further trials of antimonials in mycosis fungoides are warranted.
It is suggested that tartar emetic or other antimonials in the maximal tol-
erated doses be used in selected cases of mycosis fungoides, either alone or in
combination with other methods that affect the reticulo-endothelial system, such
as x-rays.
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